NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/30/2024
Back to search
Official data from USPTO
ALLUCENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000097978222Class
35, 41, 42, 45
Filing
97978222
Registration
7464174
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
12/03/2025
Trademark type
Combined
Nice classes
35, 41, 42, 45
Filing date
04/20/2022
Registration date
07/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/30/2024
Last transaction
12/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/01/2022
First use in commerce
05/01/2022
Drawing code
3
Owner type
03
Owner location
Cary, NC
Examiner
IN,SUNG HYUN
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word ALLUCENT appearing dark blue with the inside space of the capital letter "A" filled in with an orange triangle in the top half of the "A" that extends between the two outside lines of the "A" and a gold trapezoid in the bottom half of the "A" and the remaining letters appearing in dark blue lowercase.
Holders and representatives
Holders
Clinical Services Corporate Operations, Inc.
Clinical Services Corporate Operations, Inc.
Representatives
Laura M. Franco Winston & Strawn LLP
Technical classification
Nice Classes
Class 35Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Data managementabstraction services in the nature of extracting and summarizing information from clinical trial records and collection of medical data from clinical tests and records for business purposes; Market research and business marketing consulting services in the pharmaceuticalbiotechnologymedical devicediagnostics industries; Data managementthe management for others of databases of patient health data
Class 41
Training and development in the field of conducting clinical trialsconducting tutorialsseminars and workshops in the field of clinical trials; training in the field of computer software supportconducting tutorialsseminars and workshops in the field of software support
Class 42
Cloud computing featuring software that allows users to collectreviewanalyze and report on clinical research; technical support servicesinstallation and remote administration of softwaretroubleshooting of software problems and hosted software applicationsall for use in connection with medical research and product regulatory approvalenvironmental healthhealth carein relation to the designresearchdevelopmenttesting of new medical products and devices; cloud computing featuring software for providing telehealthtelemedicineremote care and virtual health care services to patients; cloud computing featuring software that allows users to collecttrackretrievevalidatesummarizestatistically analyze and present data used in the areas of medical research and product regulatory approvalenvironmental healthhealth carein relation to the designresearchdevelopmenttesting of new medical products and devices; Cloud computing featuring software to aggregateintegratetransfer and manage data generated from home health and remote monitoring devices and applications and health-related smart-phone applications; Cloud computing featuring software that provides integrated workflowsanalyticsvisualizationsreporting features to deliverprocessanalyzeelevatedisplay patient-generated health data; Cloud computing featuring software that integrates remotely collected health data into databasessystemsplatformsapplicationssoftware that inform clinical researchremote monitoringcare management; technical consulting servicesevaluating the safety of pharmaceuticalmedicalcosmetic and consumer devices and products in clinical development or in commercial production; Consulting services for others in the fields of designplanningimplementation and project management of clinical trials; Scientific analysis of statistical and qualitative data relating to clinical trials for pharmaceuticalsbiotechnologymedical devices and diagnostics for scientific research and for the development of pharmaceuticalbiotechnologymedical device and diagnostic products and methods of use of such devices and products
Class 45
Development of regulatory compliance strategies in the field of medical researchregulatory compliance consulting in the field of drugbiologiccosmetic and medical device development
Publications
History of USPTO decisions and trademark events.
53 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/30/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/25/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/25/2024
DOCK
ASSIGNED TO EXAMINER
06/25/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/21/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
05/21/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/02/2024
IUAF
USE AMENDMENT FILED
04/11/2024
DRRR
DIVISIONAL REQUEST RECEIVED
04/11/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
04/11/2024
EISU
TEAS STATEMENT OF USE RECEIVED
04/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/11/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/11/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/11/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/27/2024
EX1G
SOU EXTENSION 1 GRANTED
03/26/2024
EXT1
SOU EXTENSION 1 FILED
03/26/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/26/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/31/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2023
PUBO
PUBLISHED FOR OPPOSITION
09/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/16/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/29/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/29/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/29/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/29/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/29/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/13/2023
PBSR
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
07/13/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/21/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/21/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/16/2023
GNFR
FINAL REFUSAL E-MAILED
05/16/2023
CNFR
FINAL REFUSAL WRITTEN
05/16/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/06/2023
GNRT
NON-FINAL ACTION E-MAILED
01/06/2023
CNRT
NON-FINAL ACTION WRITTEN
01/06/2023
LOPR
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
01/04/2023
DOCK
ASSIGNED TO EXAMINER
12/28/2022
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
11/21/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/26/2022
NWAP
NEW APPLICATION ENTERED
04/23/2022
Continuous trademark protection
Get notified about every new filing that threatens ALLUCENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.